-
Autoimmune Biotech Scores $26M Payment, Up To $139M To Advance Phase 3 Research
Tuesday, December 6, 2022 - 12:17pm | 393Equillium Inc (NASDAQ: EQ) announced an option and asset purchase agreement through which Ono Pharmaceutical Co Ltd gains the exclusive option to purchase Equillium's rights to itolizumab. These rights include all therapeutic indications and the rights to commercialize...
-
Dynatrace Shares Drop As It Cuts FY23 Revenue Guidance; Clocks 30% Revenue Growth In Q2; Names New CFO
Wednesday, November 2, 2022 - 8:38am | 416Dynatrace, Inc (NYSE: DT) reported second-quarter FY23 revenue growth of 30% year-on-year to $279.3 million (CC), beating the consensus of $272.4 million. Total ARR increased 30% Y/Y to $1.06 billion (CC). Revenues from Subscription rose 29% Y/Y to $261.3 million (CC). Margins:...
-
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Wednesday, September 28, 2022 - 4:10am | 2238Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 106.3% to close at $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately...
-
This Analyst Boosts PT On PepsiCo? Plus UBS Sees $75 For Micron Technology
Tuesday, September 27, 2022 - 11:53am | 302Deutsche Bank raised the price target on PepsiCo, Inc. (NASDAQ: PEP) from $179 to $181. Deutsche Bank analyst Steve Powers maintained a Hold rating on the stock. PepsiCo shares fell 1.2% to $166.47 on Tuesday. UBS cut the price target for Micron Technology, Inc. (NASDAQ: MU) from $80 to $75....
-
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
Tuesday, September 27, 2022 - 11:23am | 1400Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares surged 159.9% to $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately severe pain....
-
Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal
Wednesday, September 7, 2022 - 4:58am | 393Equillium Inc (NASDAQ: EQ) has agreed to acquire Metacrine Inc (NASDAQ: MTCR) in an all-stock transaction. The transaction is anticipated to add $33 million in cash to Equillium's balance sheet at closing, which is expected to extend the company's cash runway into...
-
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
Monday, August 8, 2022 - 11:49am | 2645Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6 million for fiscal year ended March 31, 2022. Magic Empire Global Limited (NASDAQ: MEGL) surged 110...
-
89 Biggest Movers From Friday
Tuesday, June 21, 2022 - 3:44am | 2704Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. Grove Collaborative Holdings, Inc. (NYSE: GROV) rose 67.9% to close at $10.00. Grove Collaborative and Virgin Group Acquisition Corp. II announced the completion of their...
-
Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock
Tuesday, June 14, 2022 - 1:09pm | 428Olumiant (baricitinib), a Janus kinase (JAK) inhibitor, was developed by Incyte Corp (NASDAQ: INCY) and launched in collaboration with Eli Lilly And Co (NYSE: LLY), received FDA approval for hair loss disorder known as alopecia areata (AA). Olumiant was first approved for the...
-
10 Biggest Price Target Changes For Thursday
Thursday, May 19, 2022 - 7:26am | 418Telsey Advisory Group cut the price target for Bath & Body Works, Inc. (NYSE: BBWI) from $70 to $60. Bath & Body Works shares fell 6.9% to $40.00 in pre-market trading. Piper Sandler cut the price target on UWM Holdings Corporation (NYSE: UWMC) from $5 to $3. UWM Holdings shares fell 5...
-
Dynatrace Shares Gain On Q4 Beat; Discloses CFO Transition
Wednesday, May 18, 2022 - 7:48am | 247Dynatrace, Inc (NYSE: DT) reported fourth-quarter FY22 revenue growth of 31% year-on-year to $252.6 million (CC), beating the consensus of $246.6 million. Total ARR increased 29% Y/Y to $995.1 million. Revenues from Subscription rose 31% Y/Y to $239.9 million (CC). Margins:...
-
Here's How Rosenblatt Views Alteryx, Datadog, Dynatrace Ahead Of Earnings
Monday, May 2, 2022 - 2:54pm | 364Rosenblatt offers its insight on three tech stocks ahead of their earnings results in May. Alteryx, Inc (NYSE: AYX) will report Q1 results on May 3. Rosenblatt believes that the spending environment has continued to be positive in Q1 for enterprise Digital Transformation projects and low-code/...
-
Dynatrace Expands Partnership With Amazon Web Services
Thursday, March 31, 2022 - 12:41pm | 208Dynatrace Inc (NYSE: DT) has expanded its partnership with Amazon.Com Inc's (NASDAQ: AMZN) Amazon Web Services Inc (AWS). Under the partnership, Dynatrace will work with AWS to align on new product and solution development. The initiative will provide...
-
Equillium Adds Three Drugs To Its Pipeline Via Bioniz Acquisition
Wednesday, February 16, 2022 - 11:22am | 328Equillium Inc (NASDAQ: EQ), with only one asset in its pipeline, is expanding its drug development efforts via the acquisition of Bioniz Therapeutics. The deal, worth approximately $330 million, gives the biotech access to three therapeutics. Equillium will buy Bioniz in an all...
-
54 Biggest Movers From Yesterday
Thursday, February 3, 2022 - 4:21am | 1882Gainers MDJM Ltd (NASDAQ: MDJH) shares surged 35.6% to close at $2.44 on Wednesday after gaining 10% on Tuesday. GWG Holdings, Inc. (NASDAQ: GWGH) gained 31.6% to settle at $4.50. Great Panther Mining Limited (NYSE: GPL) surged 31% to close at $0.2075. Great Panther recently reported full year...